Sun Pharmaceutical Faces Market Challenges Amid Broader Sector Trends and Declining Stock Performance
Sun Pharmaceutical Industries is currently trading at Rs 1581.25, nearing its 52-week low. The stock has underperformed the pharmaceuticals sector and is below key moving averages, indicating a downward trend. Despite recent declines, the company has demonstrated strong long-term performance, with significant gains over three and five years.
Sun Pharmaceutical Industries has experienced notable activity today, reflecting ongoing trends in the pharmaceuticals and biotechnology sector. The stock is currently trading at Rs 1581.25, which is just 1.66% away from its 52-week low of Rs 1555. Today, it underperformed the sector by 0.93%, indicating a challenging market environment.In terms of moving averages, Sun Pharma is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a downward trend in its recent performance. The company's market capitalization stands at Rs 3,83,245.77 crore, classifying it as a large-cap entity. Its price-to-earnings (P/E) ratio is 33.44, slightly below the industry average of 34.52.
Over the past year, Sun Pharmaceutical Industries has seen a decline of 7.99%, contrasting with the Sensex's positive performance of 2.00%. Year-to-date, the stock has dropped by 15.24%, while the Sensex has gained 2.98%. Despite these challenges, the company has shown resilience over longer periods, with a 3-year performance of 75.43% and a 5-year performance of 203.78%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
